Bayer Supports Claritin-D Indications Claim, Not Superiority Over GSK's Flonase

Bayer supports making an “8 versus 6 FDA-approved indications” comparison with GSK's Flonase ,but it fails when suggesting Flonase doesn't relieve "sinus congestion and pressure” and “itchy throat” based only on GSK's competing product not receiving FDA approval for those indications, says NAD.

More from Marketing & Advertising

More from Business